Inventor · disambiguated record
Werner Poewe
Also filed as: POEWE WERNER
2 granted patents·5 pending applications·3 citations·filing 2007–2020
46Inventor score
Top patents by PatentIndex Score
7 records- 0168US10772890B2Use of myeloperoxidase (MPO) inhibitors or pharmaceutically acceptable salts thereof to treat multiple system atrophy (MSA) 938ASTRAZENECA AB·Filed 2018·Granted Sep 15, 2020·0 cites·2 claims
- 0266US2020405724A1Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple system atrophy (msa) 938ASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 0361US8809310B2Use of rasagiline for the treatment of multiple system atrophyPOEWE WERNER·Filed 2007·Granted Aug 19, 2014·3 cites·18 claims
- 0460US2009054468A1New Use 938ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0557US2014221400A1Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938ASTRAZENECA AB·Filed 2013·Application pending·0 cites
- 0655US2013059870A1Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938ASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 0751US2011207755A1Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938ASTRAZENECA AB·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Werner Poewe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →